VAERS reports by lot

GSK Varicella/Shingles lot 2P5E9: VAERS reports

21 VAERS reports list lot 2P5E9 as a GSK Varicella/Shingles vaccine, received between 2024-03-07 and 2024-09-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
0%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1732%
Dermatological (non-injection-site)1426%
Allergic / Anaphylactic713%
Neurological59%
Musculoskeletal36%
General / Systemic (non-local)36%
Respiratory24%
Cardiac / Cardiovascular12%
Gastrointestinal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas3
Pennsylvania2
California2
Iowa1
Michigan1
Washington1
Illinois1
Maryland1
Utah1
Indiana1
Ohio1
Rhode Island1

Reports by month received

2024-033
2024-043
2024-051
2024-064
2024-075
2024-084
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.